Anika Therapeutics Inc
NASDAQ:ANIK

Watchlist Manager
Anika Therapeutics Inc Logo
Anika Therapeutics Inc
NASDAQ:ANIK
Watchlist
Price: 17.43 USD 1.46% Market Closed
Market Cap: 255.3m USD
Have any thoughts about
Anika Therapeutics Inc?
Write Note

Wall Street
Price Targets

ANIK Price Targets Summary
Anika Therapeutics Inc

Wall Street analysts forecast ANIK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANIK is 27.03 USD with a low forecast of 25.25 USD and a high forecast of 29.4 USD.

Lowest
Price Target
25.25 USD
45% Upside
Average
Price Target
27.03 USD
55% Upside
Highest
Price Target
29.4 USD
69% Upside
Anika Therapeutics Inc Competitors:
Price Targets
IFRX
InflaRx NV
308% Upside
300896
Imeik Technology Development Co Ltd
39% Upside
4599
StemRIM Inc
99% Upside
096530
Seegene Inc
68% Upside
ALLK
Allakos Inc
224% Upside
PTGX
Protagonist Therapeutics Inc
23% Upside
301080
Acrobiosystems Co Ltd
14% Upside
2160
GNI Group Ltd
40% Upside

Revenue
Forecast

Revenue Estimate
Anika Therapeutics Inc

For the last 8 years the compound annual growth rate for Anika Therapeutics Inc's revenue is 8%. The projected CAGR for the next 3 years is -9%.

8%
Past Growth
-9%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Anika Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Anika Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ANIK's stock price target?
Price Target
27.03 USD

According to Wall Street analysts, the average 1-year price target for ANIK is 27.03 USD with a low forecast of 25.25 USD and a high forecast of 29.4 USD.

What is Anika Therapeutics Inc's Revenue forecast?
Projected CAGR
-9%

For the last 8 years the compound annual growth rate for Anika Therapeutics Inc's revenue is 8%. The projected CAGR for the next 3 years is -9%.

Back to Top